Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI.
| Image |  |
|---|---|
| Description | scientific article published on 9 July 2017 |
| Author/s |
author: Juan Berenguer Mark Bloch Pierre Côté |
| Publication date | July 9, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |